These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25675202)

  • 1. N-Octanoyl Dopamine for Donor Treatment in a Brain-death Model of Kidney and Heart Transplantation.
    Spindler RS; Schnuelle P; Nickels L; Jarczyk J; Waldherr R; Theisinger S; Theisinger B; Klotz S; Tsagogiorgas C; Göttmann U; Krämer BK; Yard BA; Hoeger S
    Transplantation; 2015 May; 99(5):935-41. PubMed ID: 25675202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-octanoyl dopamine is superior to dopamine in protecting graft contractile function when administered to the heart transplant recipients from brain-dead donors.
    Loganathan S; Guo Y; Jiang W; Radovits T; Ruppert M; Sayour AA; Brune M; Brlecic P; Gude P; Georgevici AI; Yard B; Karck M; Korkmaz-Icöz S; Szabó G
    Pharmacol Res; 2019 Dec; 150():104503. PubMed ID: 31629091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine treatment of brain-dead Fisher rats improves renal histology but not early renal function in Lewis recipients after prolonged static cold storage.
    Fontana J; Yard B; Stamellou E; Wenz H; Benck U; Schnuelle P; Hoeger S
    Transplant Proc; 2014 Dec; 46(10):3319-25. PubMed ID: 25498044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor dopamine pretreatment inhibits tubulitis in renal allografts subjected to prolonged cold preservation.
    Liu Z; Hoeger S; Schnuelle P; Feng Y; Goettmann U; Waldherr R; van der Woude FJ; Yard B
    Transplantation; 2007 Feb; 83(3):297-303. PubMed ID: 17297404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-octanoyl dopamine treatment exerts renoprotective properties in acute kidney injury but not in renal allograft recipients.
    Klotz S; Pallavi P; Tsagogiorgas C; Zimmer F; Zöllner FG; Binzen U; Greffrath W; Treede RD; Walter J; Harmsen MC; Krämer BK; Hafner M; Yard BA; Hoeger S
    Nephrol Dial Transplant; 2016 Apr; 31(4):564-73. PubMed ID: 26454224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation.
    Hoeger S; Reisenbuechler A; Gottmann U; Doyon F; Braun C; Kaya Z; Seelen MA; van Son WJ; Waldherr R; Schnuelle P; Yard BA
    Transpl Int; 2008 Nov; 21(11):1072-80. PubMed ID: 18662369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of N-acetylcysteine on apoptosis induced by myocardial ischemia reperfusion injury in rats' heart transplantation].
    Yi X; Cui X; Wu P; Wang S; Wang G; Yang X; Yang F; Zheng S; Li Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Oct; 27(10):1234-9. PubMed ID: 24397138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin donor pre-treatment in a model of brain death and allogeneic kidney transplantation in rat.
    Hoeger S; Benck U; Petrov K; Waldherr R; Schnuelle P; Yard BA; Krämer BK; Gottmann U
    Ann Transplant; 2012; 17(1):79-85. PubMed ID: 22466912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor Preconditioning After the Onset of Brain Death With Dopamine Derivate n-Octanoyl Dopamine Improves Early Posttransplant Graft Function in the Rat.
    Li S; Korkmaz-Icöz S; Radovits T; Ruppert M; Spindler R; Loganathan S; Hegedűs P; Brlecic P; Theisinger B; Theisinger S; Höger S; Brune M; Lasitschka F; Karck M; Yard B; Szabó G
    Am J Transplant; 2017 Jul; 17(7):1802-1812. PubMed ID: 28117941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additional detrimental effects of cold preservation on transplantation-associated injury in kidneys from living and brain-dead donor rats.
    Hoeger S; Petrov K; Reisenbuechler A; Fontana J; Selhorst J; Hanusch C; Beck G; Seelen MA; van Son WJ; Waldherr R; Schnuelle P; Yard BA
    Transplantation; 2009 Jan; 87(1):52-8. PubMed ID: 19136891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor.
    Pratschke J; Kofla G; Wilhelm MJ; Vergopoulos A; Laskowski I; Shaw GD; Tullius SG; Volk HD; Neuhaus P; Tilney NL
    Ann Surg; 2001 Dec; 234(6):732-40. PubMed ID: 11729379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of brain death and non-heart-beating kidney donation on renal function and injury: an assessment in the isolated perfused rat kidney.
    van den Eijnden MM; Leuvenink HG; Ottens PJ; 't Hart NA; van Oeveren W; Morariu AM; van Goor H; Ploeg RJ
    Exp Clin Transplant; 2003 Dec; 1(2):85-95. PubMed ID: 15859914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagal stimulation in brain dead donor rats decreases chronic allograft nephropathy in recipients.
    Hoeger S; Fontana J; Jarczyk J; Selhorst J; Waldherr R; Krämer BK; Schnuelle P; Yard BA
    Nephrol Dial Transplant; 2014 Mar; 29(3):544-9. PubMed ID: 24235086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor brain death significantly interferes with tolerance induction protocols.
    Francuski M; Reutzel-Selke A; Weiss S; Pascher A; Jurisch A; Ulrich F; Schumacher G; Faber W; Kohler S; Volk HD; Neuhaus P; Tullius SG; Pratschke J
    Transpl Int; 2009 Apr; 22(4):482-93. PubMed ID: 18954365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Deazaadenosine prevents leukocyte invasion by suppression of adhesion molecule expression during acute cardiac allograft rejection: involvement of apoptotic cell death.
    Fingerhuth H; Hölschermann H; Grimm H; Tillmanns H; Haberbosch W; Braun-Dullaeus RC; Stadlbauer TH
    J Heart Lung Transplant; 2004 Aug; 23(8):970-8. PubMed ID: 15312827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys.
    van der Hoeven JA; Molema G; Ter Horst GJ; Freund RL; Wiersema J; van Schilfgaarde R; Leuvenink HG; Ploeg RJ
    Kidney Int; 2003 Nov; 64(5):1874-82. PubMed ID: 14531823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deazaadenosine prevents leukozyte evasion during acute cardiac allograft rejection by suppression of adhesion molecule expression.
    Fingerhuth H; Hölschermann H; Grimm H; Schaub M; Tillmanns H; Braun-Dullaeus RC; Stadlbauer TH
    Transplant Proc; 2009; 41(6):2628-30. PubMed ID: 19715989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation.
    Dragun D; Tullius SG; Park JK; Maasch C; Lukitsch I; Lippoldt A; Gross V; Luft FC; Haller H
    Kidney Int; 1998 Aug; 54(2):590-602. PubMed ID: 9690227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.